Argelia Esperanza Rojas-Mayorquín
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Argelia Esperanza Rojas-Mayorquín has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ana Laura Márquez-Aguirre
Unidad de Biotecnología Médica y Farmacéutica, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. (CIATEJ), Guadalajara 44270, Mexico
1 shared publication - Daniel Ortuño-Sahagún
Laboratorio de Neuroinmunobiología Molecular, Instituto de Neurociencias Traslacionales, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara
1 shared publication - José de Jesús Guerrero-García
Banco de Sangre Central, Unidad Médica de Alta Especialidad (UMAE), Hospital de Especialidades (HE), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico
1 shared publication - Lucrecia Carrera-Quintanar
Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Departamento de Alimentación y Nutrición, Doctorado en Ciencias de la Nutrición Traslacional, Guadalajara 44340, Jalisco, Mexico
1 shared publication - Rocío Ivette López-Roa
Laboratorio de Investigación y Desarrollo Farmacéutico, Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico
1 shared publication
Latest Publications
- Open Access
- 1 January 2016
- Published by Wiley in Mediators of Inflammation
- Vol. 2016, 1-24
Multiple Sclerosis and Obesity: Possible Roles of Adipokines
Multiple Sclerosis (MS) is an autoimmune disorder of the Central Nervous System that has been associated with several environmental factors, such as diet and obesity. The possible link between MS and obesity has become more interesting in recent years since the discovery of the remarkable properties of adipose tissue. Once MS is initiated, obesity can contribute to increased disease severity by negatively influencing disease progress and treatment response, but, also, obesity in early life is highly relevant as a susceptibility factor and causally related risk for late MS development. The aim of this review was to discuss recent evidence about the link between obesity, as a chronic inflammatory state, and the pathogenesis of MS as a chronic autoimmune and inflammatory disease. First, we describe the main cells involved in MS pathogenesis, both from neural tissue and from the immune system, and including a new participant, the adipocyte, focusing on their roles in MS. Second, we concentrate on the role of several adipokines that are able to participate in the mediation of the immune response in MS and on the possible cross talk between the latter. Finally, we explore recent therapy that involves the transplantation of adipocyte precursor cells for the treatment of MS.
- 1 January 2016
- Published by Wiley in Mediators of Inflammation
- Vol. 2016, 1-24
Open AccessMultiple Sclerosis and Obesity: Possible Roles of Adipokines
Multiple Sclerosis (MS) is an autoimmune disorder of the Central Nervous System that has been associated with several environmental factors, such as diet and obesity. The possible link between MS and obesity has become more interesting in recent years since the discovery of the remarkable properties of adipose tissue. Once MS is initiated, obesity can contribute to increased disease severity by negatively influencing disease progress and treatment response, but, also, obesity in early life is highly relevant as a susceptibility factor and causally related risk for late MS development. The aim of this review was to discuss recent evidence about the link between obesity, as a chronic inflammatory state, and the pathogenesis of MS as a chronic autoimmune and inflammatory disease. First, we describe the main cells involved in MS pathogenesis, both from neural tissue and from the immune system, and including a new participant, the adipocyte, focusing on their roles in MS. Second, we concentrate on the role of several adipokines that are able to participate in the mediation of the immune response in MS and on the possible cross talk between the latter. Finally, we explore recent therapy that involves the transplantation of adipocyte precursor cells for the treatment of MS.